Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by Betteryear2on Nov 09, 2021 1:55pm
212 Views
Post# 34105770

Q3 Financial Results & hold Conference Call on November 16th

Q3 Financial Results & hold Conference Call on November 16th

TORONTO, ON / ACCESSWIRE / November 9, 2021 / StageZero Life Sciences (TSX:SZLS) (OTCQB:SZLSF) ("StageZero" or the "Company"), a healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through lab developed tests and clinical interventions, today announced that it will release its third-quarter 2021 operational results after the market closes on Monday November 15, 2021. Management will host a live conference call and accompanying webcast at 8:30 a.m. EST on Tuesday, November 16, 2021, to review the operational results and discuss business developments.

Analyst and Investor Call

Event Date: Tuesday, November 16, 2021
Time: 8:30 a.m. EST
Webcast Linkhttps://www.webcaster4.com/Webcast/Page/2082/43507
Participant Numbers:

Toll Free: 877-545-0523
International: 973-528-0016
Participant Access Code: 236178

Replay Number:

Toll Free: 877-481-4010
International: 919-882-2331
Replay Passcode: 43507


https://www.accesswire.com/671943/StageZero-to-Issue-Q3-2021-Financial-Results-and-Hold-Conference-Call-on-Tuesday-November-16

<< Previous
Bullboard Posts
Next >>